Recent policy shifts in these two influential health technology assessment markets signal a broader regional move toward faster, more innovation-friendly access frameworks.
Joshua Siow
Advertisement
Partner, Singapore, with Simon-Kucher & Partners’ life sciences division
Articles by Joshua Siow
Country is poised to offer growth-channel opportunities for global pharma companies ready to scale access, innovation, and profitability.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
2
How Will the Inclusion of GLP-1s in Medicaid and Medicare Impact Businesses?
3
How are New FDA Programs Impacting Neuroscience?
4
Will the Industry Continue to Research Psychedelics?
5
